Ann: Commencement of Larger Animal Studies for Lead Program, page-11

Hi Hottod ... thanks for the reply. I accept that my 12 months quote when compared to the AGM is exaggerated (unintentionallly). I had in mind that I queried the delays at the AGM as I had been eagerly awaiting solid progress and the dates seemed to be constantly shifting. And so, I had 12 months in my head - sorry about that. Here is my progress on this topic:

Sept 2019 Shareholder Update
Large animal Toxicity studies by Q2 2020 (now Q4/2021)

June 2020 milestones
Acute animal toxicity data 2H 2020.
Commencing human trials 2H 2021

August 2020 milestones.
IND filing with the FDA by 2H21. (now mid2022)
Acute toxicity studies in Rabbits and Monkeys by Q1/2021 (didn't happen)

Oct 2020 milestones.
Toxicology results in rabbits and monkeys in 1H 2021 (Didn't happen)

AGM Nov 2020 milestones.
Large animal toxicity (Q1/2 2021) (Didn't happen)

Latest Update July 2021.
PYC is on track to submit an Investigational New Drug (IND) application in mid-2022.
PYC anticipates releasing the results from these studies in rabbits in Q3 2021 and then from the remaining studies in rabbits and non-human primates in early Q4 2021. (Fingers are crossed)

As you can see it is a moving feast. Now, I'm not so critical of the delays as i accept that everyone is focussed on getting the best outcomes. But I am critical of the lack of explanation.